Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Basal Cell × Imiquimod × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Squamous Intraepithelial Lesions 1 Skin Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Melanoma 1 Leukoplakia 1 Leukokeratosis, Hereditary Mucosal 1 HIV Infections 1 Glioma 1 Glioblastoma 1 Ependymoma 1 Colorectal Neoplasms 1 Carcinoma, Basal Cell 1

Interventions

cemiplimab 5 Nivolumab 4 pembrolizumab 3 Specimen Handling 3 Radiotherapy 3 Biopsy 3 Surgical Procedures, Operative 2 Standard of Care 2 Photochemotherapy 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 CTLA-4 Antigen 2 Aminolevulinic Acid 2 tocilizumab 1 talimogene laherparepvec 1 sonidegib 1 relatlimab 1 prednylidene 1 poly ICLC 1 methyl 5-aminolevulinate 1 flt3 ligand protein 1 deltacortene 1 daromun 1 Watchful Waiting 1 Vitamin D 1 Tomography, Optical Coherence 1 Sunscreening Agents 1 Sirolimus 1 Risk Factors 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03534947 2025-12-16

SONIB

Melanoma Institute Australia

Phase 2 Completed

Carcinoma, Basal Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡